A Novel Personalized Treatment Approach for Psoriasis: Anti-VEGF-A Therapy

Vascular endothelial growth factor A (VEGF-A) mediates angiogenesis and is upregulated in the plaques and plasma of patients with psoriasis. Targeting VEGF-A in in vivo models of psoriasis-like inflammation results in disease clearance.